The color of the phlegm from patients with the lung disease bronchiectasis can indicate the degree of inflammation in their lungs and predict their future outcomes, according to new research presented at the European Respiratory Society International Congress in Milan, Italy, on Sunday.
Adults with bronchiectasis and a Pseudomonas aeruginosa infection had lower bacterial density and better quality of life when treated with tobramycin inhalation solution, according to study results published in CHEST.“In adult patients with bronchiectasis with P. aeruginosa infection, two cycles of tobramycin inhalation solution nebulization significantly reduce the sputum P. aeruginosa
FRIDAY, Feb. 25, 2022 (HealthDay News) Continuous positive airway pressure (CPAP) treatment may not benefit very elderly individuals with obstructive sleep apnea (OSA), according to a study published in the January issue of Sleep Medicine. Miguel Angel Martinez-Garcia, Ph.D., M.D., from the Hospital Universitario y Politecnico La Fe in Valencia, Spain, and colleagues assessed […]
FRIDAY, Feb. 25, 2022 (HealthDay News) Continuous positive airway pressure (CPAP) treatment may not benefit very elderly individuals with obstructive sleep apnea (OSA), according to a study published in